In AD models, down-regulation of ZKSCAN3 expression leads to significant up-regulation of the expression of its downstream lysosome-related genes (e.g., GRB2, Lamp2), which promotes lysosomal generation and enhanced function [96,97]. This evidence concerns the gene ZKSCAN3 and Alzheimer disease.